OPEN END TURBO OPTIONSSCHEIN LONG - BAXTER INTERNATIONAL Stock

Certificat

DE000GG7VD69

Real-time BOERSE MUENCHEN 06:27:28 2024-07-17 am EDT
0.649 EUR +21.99% Intraday chart for OPEN END TURBO OPTIONSSCHEIN LONG - BAXTER INTERNATIONAL
Current month+24.30%
1 month+16.67%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-17 0.649 +21.99%
24-07-16 0.532 +10.37%
24-07-15 0.482 -18.31%
24-07-12 0.59 +3.15%
24-07-11 0.572 +23.01%

Real-time BOERSE MUENCHEN

Last update July 17, 2024 at 06:27 am EDT

More quotes

Static data

Product typeWarrant Knock-Out senza Stop Loss
Buy / SellCALL
Underlying BAXTER INTERNATIONAL INC.
Issuer Goldman Sachs
WKN GG7VD6
ISINDE000GG7VD69
Date issued 2024-05-08
Strike 29.25 $
Maturity Unlimited
Parity 10 : 1
Emission price 0.67
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.685
Lowest since issue 0.367
Spread 0.01
Spread %1.52%

Company Profile

Baxter International Inc. specializes in the development, manufacturing and marketing of medical devices and medications intended for healthcare professionals. Net sales break down by family of products as follows: - medicines and medical devices (33.8%): products intended for treating hemophilia (substitution clotting factors) and immune deficiencies (multi-purpose immunoglobins), and used in intensive care (human albumin) and biosurgery (fibrin adhesive, surgical gel, bone substitutes, hemostatic compresses, etc.); - kidney dialysis drugs and equipment (30.1%); - systems for delivering medications and intravenous therapy (15.2%): used in the fields of anesthesia, oncology (chemotherapy and radiation), parenteral nutrition, etc.; - other (20.1%). Export accounts for 52.7% of net sales.
Sector
-
More about the company

Ratings for Baxter International Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Baxter International Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
35.54 USD
Average target price
44.75 USD
Spread / Average Target
+25.91%
Consensus